Compared with the previous studies that measured HER2 ratios of gastric cancer patients using ddPCR19–24, our study covered the largest cohort to the best of our knowledge; moreover, we worked with paired samples of formalin-fixed and paraffin-embedded (FFPE) tissues and preoperative plasma cfDNA. This evidence concerns the gene ERBB2 and gastric cancer.